BridgeBio Pharma, Inc. (BBIO) Price Target Raised to $56 from $53 at H.C. Wainwright
BridgeBio Pharma, Inc. (NASDAQ:BBIO) is one of the 13 Biotech Stocks with Huge Upside Potential. In a recent report, Raghuram Selvaraju, an expert at H.C.
Posts Tagged ‘NASDAQ:BBIO’
13 Biotech Stocks with Huge Upside Potential
The FDA Commissioner Marty Makary stated the FDA will reach its 2025 drug approval targets despite severe workforce reductions.
BMO Maintains Hold on BridgeBio (BBIO) Amid Intensifying Competition
On June 3, BMO Capital Markets analyst Kostas Biliouris reiterated a Hold rating on BridgeBio Pharma Inc. (NASDAQ:BBIO) with an unchanged price target of $37.
BridgeBio’s Acoramidis: A Breakthrough in ATTR-CM Treatment
On May 19, BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Q1 2025 Earnings Call Transcript
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Q1 2025 Earnings Call Transcript April 29, 2025BridgeBio Pharma, Inc. beats earnings expectations.
Billionaire Andreas Halvorsen’s 10 Stock Picks With Huge Upside Potential
Ole Andreas Halvorsen is one of the prominent names among former employees of Julian Robertson's Tiger Management.
10 Best Mid Cap Biotech Stocks to Buy
On March 6, Jared Holz, Mizuho health care equity strategist, appeared on CNBC's 'Power Lunch' to discuss investing in biotech and the oversaturation in the sector.
10 Best Performing Mid Cap Stocks to Buy According to Analysts
On February 7, Simeon Hyman, Global Investment Strategist at ProShares Advisors, appeared on CNBC to discuss the upcoming jobs report and its expected impact on the market.
10 Best Performing Pharma Stocks So Far in 2025
On February 20, Jared Holz, Mizuho healthcare sector strategist, appeared on 'Squawk Box' to discuss the potential challenges and opportunities the pharmaceutical industry may...
12 Best Healthcare Stocks to Buy According to Analysts
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.
10 Unstoppable Stocks to Buy in 2025
As per the recent earnings update by FactSet dated 24th January 2025, the Q4 2024 earnings season for the S&P 500 has seen a strong start.
Why These 15 Stocks Are Skyrocketing in 2025
Stock gains always get people talking, and 2025 is no exception. Markets have moved higher for a while due to a shift toward tech innovation.
Billionaire Andreas Halvorsen’s Top 15 Long-Term Stock Picks
Andreas Halvorsen is a prominent Norwegian hedge fund manager and the co-founder of Viking Global, one of the most successful equity-focused hedge funds in the world.
10 Worst Performing Biotech Stocks in 2024
Biotechnology stocks are among the most volatile in the market due to their high risk.
10 Best Healthcare Stocks to Buy Under $50
This article looks at the 10 best healthcare stocks to buy under $50.
14 Best Medical Stocks To Invest In According to Hedge Funds
In this piece, we will take a look at the 14 best medical stocks to invest in according to hedge funds.
16 Best Mid-Cap Growth Stocks To Buy Now
In this article, we will take a detailed look at the 16 Best Mid-Cap Growth Stocks To Buy Now. For a quick overview of such stocks, read our article 5 Best Mid-Cap Growth...
13 High Growth Healthcare Stocks to Buy
In this article, we will take a look at 13 high growth healthcare stocks to buy.
12 Most Promising Stocks to Buy According to Hedge Funds
In this article, we will take a look at the 12 most promising stocks to buy according to hedge funds.
12 Best Performing Biotech Stocks in 2023
In this piece, we will take a look at the 12 best performing biotechnology stocks in 2023.
5 Best High Risk High Reward Stocks To Buy Now
In this piece, we will take a look at the five best high risk high reward stocks to buy now.
5 Best Performing Stocks in the Last 3 Months
In this article, we discuss 5 best performing stocks in the last 3 months.
15 Best Performing Stocks in the Last 6 Months
In this article, we discuss 15 best performing stocks in the last 6 months.
5 Best Healthcare Stocks Under $50
In this article, we will be taking a look at the 5 best healthcare stocks under $50.
Viking Global’s 5 Long-Term Stock Picks
In this article, we discuss Viking Global's 5 long-term stock picks.
5 Best Stocks Under $20 According to Billionaire Andreas Halvorsen’s Viking Global
In this piece, we will take a look at the top five best stocks to buy under $20 according to billionaire Andreas Halvorsen's Viking Global.
5 Stocks to Buy According to Billionaire Andreas Halvorsen’s Viking Global
In this article, we discuss the 5 stocks to buy according to billionaire Andreas Halvorsen's Viking Global.
Viking Global’s Top 5 Stocks
Humana Inc. (NYSE:HUM), a health insurance company, is one of the top stocks in Viking Global's portfolio.
5 Biotech Stocks To Buy According To Chinese Billionaire Lei Zhang
In this article, we discuss 5 biotech stocks to buy according to Chinese billionaire Lei Zhang.
Hedge Fund and Insider Trading News: Chris Rokos, David Tepper, Paul Tudor Jones, Greenlight Capital, Bridgewater Associates, D.E. Shaw, FSD Pharma Inc (HUGE), Savara Inc (SVRA), and More
Bridgewater Associates named two new co-chief executives to head the world’s largest hedge-fund firm on Monday, after CEO David McCormick told staff he would be stepping down...
Top 10 Stock Picks of Chinese Billionaire Lei Zhang
In this article, we discuss the top 10 stock picks of the Chinese billionaire Lei Zhang.
5 New Stock Picks of Billionaire Ken Fisher
In this article, we discuss the 5 new stock picks of billionaire Ken Fisher.
Hedge Funds Are Piling Into BridgeBio Pharma, Inc. (BBIO)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of...
5 Best Biotech Stocks to Buy According to Joseph Edelman’s Perceptive Advisors
In this article, we will discuss the 5 best biotech stocks to buy according to Joseph Edelman's Perceptive Advisors based on Q2 holdings of the fund.
Should You Be Tempted To ‘Sell’ BridgeBio Pharma (BBIO) Stock?
Baron Opportunity Fund recently published its second-quarter commentary – a copy of which can be downloaded here.
10 Best Stocks to Invest In According to Chinese Billionaire Lei Zhang
In this article, we will discuss 10 best stocks to invest in according to Chinese billionaire Lei Zhang based on Q1 holdings of the fund.
Baron Funds: “We Retain Conviction in BridgeBio (BBIO)”
Baron Funds, an asset management firm, published its “Baron Health Care Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
Hedge Funds Are Crazy About BridgeBio Pharma, Inc. (BBIO)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
10 Best Stocks to Buy According to DiDi (NYSE: DIDI)’s Early Investor Billionaire Zhang Lei
In this article we will take a look at the 10 best stocks to buy according to billionaire Zhang Lei, who was an early investor in DiDi Global Inc - ADR (NYSE: DIDI).
Is BridgeBio Pharma Inc. (BBIO) A Smart Long-Term Buy?
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2021 investor letter – a copy of which can be downloaded here.
Is BBIO Stock A Buy or Sell?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
10 Best Hong Kong Stocks To Buy For 2021
In this article, we discussed Chinese billionaire Zhang Lei's investment philosophy and his 10 best Hong Kong stocks to buy for 2021.
Is BridgeBio Pharma (BBIO) Stock a Buy For 2021?
Baron Health Care Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here.
Billionaire Andreas Halvorsen’s Top 10 Stock Picks
The billionaire Andreas Halvorsen's Viking Global Investors LP has beaten the broader market index in 2020 by returning 25% after management and performance fees.
10 Best Biotech Stocks to Invest In According To Billionaire Biotech Hedge Fund
In this article, we will present the 10 best stocks to invest in according to the billionaire biotech hedge fund manager Joe Edelman.
Is BBIO A Good Stock To Buy Now?
In this article you are going to find out whether hedge funds think BridgeBio Pharma, Inc. (NASDAQ:BBIO) is a good investment right now.
Hedge Funds Are Nibbling On BridgeBio Pharma, Inc. (BBIO)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Is BridgeBio Pharma, Inc. (BBIO) A Good Stock To Buy?
We hate to say this but, we told you so.
BridgeBio Pharma, Inc. (BBIO): Are Hedge Funds Right About This Stock?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
